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    Dd/s strain mice, maV and female, were lethally irradiated with gamma-rays under 
 high dose rate and were treated with homologous na2 strain mouse bone marrow. 
 Although a 14 day survival rate was fairy good, 30 day survival was generally low 
 except for experiment No. 2 using female mice. However, most of the mice which 
 survived for the initial 30 days in experiment No. 2 died during the subsequnt 30 days. 
INTRODUCTION 
   The effect of isologous bone marrow on lethally irradiated mice was des-
cribed in Report I'1'. Isologous bone marrow, however, can be obtained only 
in mice or a few other animal species in which there are inbred strains. 
The results of animal experiments with isologous bone marrow treatment are 
appli';able to humans only in the case of uniovular twins. Thus from a 
practical point of view, bone marrow treatment of an irradiated recipient 
which belongs to the same species as the donor but differs genetically is much 
more important than isologous bone marrow treatment. The following is the 
result of homologous bone marrow treatment in mice lethally irradiated with 
gamma-rays under high dose rate. 
                     MATERIALS AND METHODS 
   Inbred dd/s strain mice, male and female, were used as irradiated bone 
marrow recipients. Inbred na2 strain mice were used as bone marrow donors. 
Both the donors and recipients were 2 to 2-2-- months old. The method of 
obtaining bone marrow suspensions and the conditions of irradiation were 
described in Report I211. Mice in experiment No. 1 and 2 were irradiated at 
place B and others at place A. 
RESULTS 
   1) Survival Rate 
    Survival rates of mice in several experiments are shown in Table 1. The 
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Table 1. Survival rate of gamma-irradiated mice treated with homologous bone marrow. 
                           No. of Survival No. of living/No. % Ser-
 Experi- Dose Dosenucleatedof irradiatedvival 
 ment Sex rate (r
)cells-------~~--.   No.(r/min.)inje1 0tedday14 21 30 60 90days90  
   1S318 900 1,7- 5,6T 8/13 5/12 2/12 2/12 1/12 1/12 17 8                               C 9/11 1/11 1/11 1/11 1/11 1/11 9 9 
   2 2 318 900 3.2 ~3,6T13/13 11/12 11/12 9/11 3/10 3/10 92 30                              C 7/7 1/7 1/7 7 1 7 1/7 14 14 
   363500 875 7 6T 9/16 4/16 3/16 2/16 1/16 1/16 19 6 C11/12 0 0 0 
   4 3 3470 752 6,0 T13/14 7/13 4/13 1/13 1/13 1/13 31 8 C 8/8 0/80 0 
  5 2 3390 848 7.8 T 6/8 4/8 2/8 0/825 0                         C 2/4 1/4 1/4 1/4 0/4 25 0 
   T : Treated C : Control 
difference in survival rate in experiment No. 1 between the treated mice and 
the controls is not significant, but that in experiment No. 2 is significant 
with 99% probability. Twenty one day survival rates of the irradiated and 
treated mice were higher than the controls in most of the experiments, but 
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Fig. 1. Individual weight change in gamma-irradiated mice treated with homologous 
    Bone marrow. (Experiment No. 2) 
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decreased further. The survival rate of the treated mice in experiment No. 2 
was  929(; at 21 days, but decreased to 309(; at 60 days. The main causes of death 
in mice dying between 21st and 60th day were pneumonia, sepsis, and intestinal 
hemorrhage just as in those dying before the 21st day. In a long term observa 
tion, the last mouse in the treated group in experiment No. 1 died at 205 days, and 
in experiment No. 2 three treated ones died at 120, 180 and 274 days and one 
of the controls at 109 days. Further, the last mouse in experiments No. 3 and 
4 died at 117 days and 96 days, respectively. No apparent cause of death was 
found in most of the mice dying after 90 days. 
   2) Body Weight Changes 
   The mean weight changes do not show the tendency of weight change in 
individual animal, if mice which are gaining weight and those which are 
losing weight are inculded in a same group. Individual weight changes of six 
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            homologous bone marrow. 
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representative animals in experiment No. 2 are shown in Fig. 1. From this 
figure three types of weight changes are noted. a) Mice which showed a rapid 
and continuous decrease of body weight which went too far to be compensated 
by a terminal recovery. b) Mice which showed a moderate degree of weight 
loss followed by its gradual increase beginning around the 20th day. c) Mice 
which showed a rather slight degree of weight loss followed by a tendency to 
increase by the 20th day. Then the body weight started to decrease rapidly 
and the mice died between 30 and 60 days. The weight change of type-a was 
approximately the same as that of the controls, showing no favorable effects 
of bone marrow treatment. The weight change of type-b was approximately 
the same as that of mice treated with isologous bone marrow, though there 
was a longer period of initial body weight decrease in the former. The weight 
„., 
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  Fig. 3. Reticulocyte, platelet, and leucocyte count in gamma-irradiated mice treated 
    with homologous bone marrow. 
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change of type-c was seen exclusively with homologous bone marrow treatment. 
   3) Hematological findings (Figs. 2 and 3) 
   Changes of peripheral erythrocyte count, leucocyte count, hemoglobin con-
tent, reticulocyte count, and platelet count after gamma-irradiation and homo-
logous bone marrow treatment were essentially the same as those in mice 
gamma-irradiated and treated with isologous bone marrow (21). Most of the 
mice dying between 21 and 60 days had almost normal blood cell count except 
for. a few with a moderate decrease in leucocyte count. 
   4) Histological findings 
Histologkal findings in the bone marrow and the spleen during the period 
immediately after irradiation and the beginning of recovery were the same as 
with isologous bone marrow treatment : complete wasting within 48 hours after 
irradiation followed by spotty regeneration of the bone marrow and early 
phase of the recovery of the red pulp of the spleen beginning at 4 or 5 days. 
A rapid recovery to normal cellularity followed. All of the mice dying between 
30 and 60 days had normal cellularity of their bone marrow except for one 
which had only 25° of normal. There was no difference in the speed of 
regeneration of the red pulp of the spleen between homologously and isolo-
gously treated mice, but the recovery of the white pulp in the former showed 
much delay beginning no earlier than the ninth week. There was no evidence 
of regeneration of the lymphnodes during 21 day observation period in both 
groups. The regeneration of the inguinal lymphnodes was observed for the 
first time at 41 days and not earlier in the treated group. In no animal did 
the thymus show evidence of regeneration before the 40th day, much slower 
than in those irradiated and treated with isologous bone marrow. As for 
changes in other organs, submucosal edema of the small intestine, and focal 
necrosis or abscess of the liver were occasionally found in the treated mice. 
                           DISCUSSION 
   The fact that mice fatally irradiated and treated with homologous bone 
marrow survived for the first 3 to 4 weeks with survival rate almost equal 
to that of isologously treated mice, and that they died in the subsequent 60 
days was reported by Congdon et al.31 and others. A kind of immune reaction 
has been thought to be involved in this phenomenon in which the mice treated 
with homologous bone marrow lose weight despite normal food intake leading 
to death. The speed of recovery of the bone marrow was the same as that 
in mice treated with isologous bone marrow, but there were differences in 
other organs, viz., a delay in regeneration of the white pulp of the spleen, 
thymus and lymphnode. The exact cause of this delay in regeneration of the 
lymphatic organs is not known, but may be due either to the direct effect of 
the immune reaction or indirectly to metabolic effects caused by the immune 
reaction. Congdon et al.° stated that extreme atrophy of the white pulp of 
the spleen and lymphnodes was due to exhaustion in the presence of large 
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numbers of foreign cells which became strong stimuli to the host. They also 
stated that the thymus recovered temporarily followed by a simple atrophy, 
and that this secondary atrophy of the thymus might  be related to the ema-
ciated condition of the mice. In the present study temporary regeneration 
of the thymus was not observed, however. 
   There are two theories concerning the antigen and antibody involved in 
the immune reaction described above. One is that donor (graft) cells become 
an antigen and sensitize the host tissue, and the other is that the host tissue 
becomes an antigen, sensitizing the graft. Should an immune reaction occur 
by the former process, it is called a host-to-graft reaction, and if by the latter, 
a graft-to-host reaction. As experimental data in favor of the former theory, 
Gengozian et al."' observed the antibody response of lethally irradiated mice 
treated with either mouse or rat bone marrow. a) Irradiated mice treated 
with isologous mouse marrow responded at 30 days differently to sheep RBC 
antigen and rat RBC antigen. If donor tissue is responsible for antibody 
formation, then the response to both antigens should be the same as seen 
in normal mice. b) The response to both antigens recovered gradually, and 
this might mean a recovery of the irradiation damaged antibody-forming 
tissue of the host. c) In irradiated mice treated with heterologous bone mar-
row, there was no response to isologous mouse RBC antigen. If antibody 
producing cells were those of the donor (rat), there should be a response to 
mouse RBC. d) The response to sheep RBC was weak. Since sheep RBC 
antigens are foreign to both mouse and rat antibody-forming tissues, the 
response to this antigen should be additive. Makinodan`'' was unable to find 
rat serum protein in the serum of rat marrow protected mice by the serum-
agar method. 1here has been no direct evidence for transplantation of non-
granulocytes. When mice were pre-sensitized to foreign bone marrow cells 
before irradiation, a higher per centage of mice died earlier than those without 
pre-sensitization''' 
   As for the experimental data in favor of the latter, graft-to-host reaction 
theory, Trentinl" stated that the essentially normal blood count of mice treated 
with homologous marrow at the time of their late death and the long duration 
of skin homograft without sloughing did not accord with the former theory. 
Uphoff"' observed that delayed death did not take place when lethally irradiated 
parent strain mice were treated with Fl hybrid mouse marrow, but did in the 
reverse situation. Since Fl hybrid has all the antigenic components of a parent 
strain, the former does not form antibodies to the latter. On the other hand 
the former has antigenic components not shared with the latter, which should 
form antibodies to the former. Thus Uphoff's experiment gave support to the 
graft-to-host reaction theory. He also extended the study of the Fl hybrid effect 
in making a F1 hybrid of two parent strains which were different only in histo-
compatihtlity-2 locus of chromosome to each other1p7. If the graft-to-host reac-
tion is the case, using the fetal tissue as a donor should preclude immune 
reactions ; this was confirmed by Uphoff '' but not by Congdon el al.4' Though 
Congdon was unable to find rat serum protein in rat marrow protected mice, 
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Weyzen  et a1.20' reported that rat gamma globulin was demonstrated by precipi-
tation with anti-rat serum and by micro-immuno-electrophoresis. 
However, there are several studies and opinions against the graft-to-host 
reaction theory. Fox') stated that one dominant gene one antigen concept which 
formed the basis of Uphoff's opinion'5,'1' could not be applicable in all situations. 
   Even if rat gamma globulin was found in rat marrow protected mice there 
is no evidence to prove that it is an antibody to the mouse tissue. There have 
been increasing evidence to support the openion that antibody-forming cells 
are plasma cells2). There are usually no plasma cells in the normal mouse 
bone marrow2S'. Even if they are found in the bone marrow of the mouse they 
may be mostly mature in type as in the case of human bone marrow and do 
not appear to proliferate readily upon stimulationi''. So it is doubtbul that 
enough plasma cells proliferate to make enough antibody to kill the host. The 
mechanism of delayed death in irradiated animals protected by homologous 
bone marrow needs to be studied further. 
   In the present study, survival of irradiated mice protected by homologous 
bone marrow was generally less than that of mice protected by isologous bone 
marrow except for the female mice in experiment No. 2. In Report I also, 
female mice responded better to isologous bone marrow treatment. Although 
Abrams') observed no sex difference in X-irradiation sensitivity, Watanabee') 
found female mice less sensitive than male mice and Langendorf et al .8' ob-
served also that female mice were less sensitive but became sensitive when 
they were castrated. As for the ability to respond to bone marrow protection 
Urso et al."' observed the tendency for male mice to recover with relatively 
smaller dose of bone marrow but the difference was small. Other workers 
usually did not comment on the sex difference in this aspect and there was 
presumably no difference. Estrogen has been known to reduce radiation 
mortality'2.' and pre-treatment with estrogen supplements the effect of bone 
marrow treatment after irradiation'". Thus it is not surprising to obtain 
better survival rate in females after irradiation and bone marrow pro-
tection. 
   In the present study, a thirty day survival rate of mice was compara-
tively low except for experiment No. 2. However, a 14 day survival rate 
was fairly good. The antibody-forming tissue of the host may have recovered 
earlier than in experiments using the same dose of X-rays because of the 
low RBE of gamma-rays. Gengozian et al.'' reported that sublethally irradiated 
mice died early with homologous bone marrow treatment. Even Trentin, who 
supports the graft-to-host reaction theory in the case of lethal irradiation, 
agrees with the host-to-graft reaction theory in the case of high sublethal ir-
radiation"). 
   The author is indebted to Professor G. Wakisaka, M. D. and Dr. H. Ichida 
for their suggestions and advices in carrying out the study reported, here and 
thanks are extended to Mr. Y. Nakayama of the Institute for Chemical Rese-
arch of Kyoto University, for his kindness in frequently operating the Co'" 
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irradiation facility. 
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